Full-Time

Senior Therapeutic Area Specialist

Cardiovascular Community, CV

Posted on 6/23/2025

Deadline 6/30/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Compensation Overview

$110k - $150k/yr

+ Incentive Cash + Stock Opportunities

Senior

Company Historically Provides H1B Sponsorship

Rochester, MN, USA

In Person

The position is field-based, indicating that the candidate will be required to work in-person in the Rochester area.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Advanced scientific degree and/or preferred 5+ years of pharmaceutical or biotechnology experience as healthcare sales / MSL / HCP / nurse.
  • Ability to communicate scientific or clinical data accurately and convincingly to help physicians best serve their patients.
  • Demonstrated experience building and maintaining strong credibility with key customers, office staff, and others in the customer influence network via a customer-centric mindset and desire to create positive and differentiated Customer Experience (Cx).
  • Demonstrated strong capability in account management skill sets, superior selling competencies, and proven sales performance track record of meeting or exceeding goals.
  • Demonstrated ability to work effectively cross-functionally with a positive team mindset and can-do attitude.
  • Strong selling and promotional skills proven through a track record of performance.
Responsibilities
  • Promotes approved indications of BMS products within a defined territory or region to meet or exceed assigned sales targets in a compliant manner.
  • Creates demand for BMS medicines by articulating in a balanced manner the clinical and scientific rationale for use of products in appropriate patients.
  • Engages with and continuously maintains/grows a high level of scientific expertise in all assigned products and therapeutic areas.
  • Prepares and successfully implements comprehensive territory and account plans.
  • Proactively uses available tools such as SOPHIA to derive insights and to dynamically inform call plans.
  • Provides feedback on experience using these tools to leadership to enable continuous improvement.
  • Demonstrates scientific expertise and passion in using approved scientific resources and publications to present information to HCPs and ensures medical accuracy.
  • Conducts in-office presentations (e.g., lunch and learns) and discusses product-related scientific information with HCPs that is consistent with label.
  • Organizes external speaker programs, selecting speakers from list approved by Speakers Bureau and facilitating scheduling and logistics.
  • Maintains a high level of working expertise on emerging data for approved indications.
  • Engages real-time medical support through Medical on Call to reactively answer unsolicited questions and complex technical inquiries.
  • Proactively collaborates with other field teams to ensure the best Customer Experience (Cx) for HCPs.
  • Gathers and shares relevant insights and information internally with the appropriate stakeholders to enable BMS to better serve its customers.
  • Complies with all laws, regulations, and policies that govern the conduct of BMS.
Desired Qualifications
  • Experience in cardiovascular preferred.
  • Customer/commercial mindset. Demonstrated ability to drive business results.
  • Experience identifying, engaging, and cultivating credibility with customers across the patient care journey.
  • Demonstrated account management skills and problem-solving mentality. Understands the patient journey and can customize engagement and deliver tailored messages.
  • Demonstrated resourcefulness and ability to connect with customers.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • Chris Shibutani's appointment may drive strategic growth and innovation at BMS.
  • Advancements in targeted protein degradation enhance therapeutic offerings in oncology.
  • Partnership with BioNTech could provide a competitive edge against Merck's Keytruda.

What critics are saying

  • Antitrust litigation over Pomalyst could impact BMS's market position in oncology.
  • Reliance on real-world data presents challenges in data quality and implementation.
  • High costs and technical challenges in space research could affect treatment feasibility.

What makes Bristol Myers Squibb unique

  • BMS collaborates with BioNTech for next-gen cancer immunotherapy, enhancing oncology portfolio.
  • Focus on real-world data strategies could lead to faster drug market entry.
  • Developing bone disease treatments in space positions BMS as a leader in innovative research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

ISS National Lab
Jul 7th, 2025
This is Not the Time to Cut Space-enabled Medical Research

Bristol-Myers Squibb is developing novel bone disease treatments in space, and the National Stem Cell Foundation is studying 3D brain organoids derived from patients with Parkinson's disease in microgravity to observe disease progression more rapidly with the aim of identifying potential biomarkers for early diagnosis and therapeutic targets.

The Pharma Letter
Jun 26th, 2025
Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst

Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst.

Unlearn
Jun 24th, 2025
The Best 15 Minutes You'll Spend on Clinical Trials Today

At the 2025 "Digital Breakthrough for Pharma" Summit hosted by Bristol Myers Squibb, Unlearn's co-founder and machine learning scientist, Aaron Smith, took the stage to explain exactly how that vision is now a reality.

ROI-NJ
Jun 13th, 2025
Bristol Myers Squibb Names Shibutani As Evp, Chief Strategy Officer

Bristol Myers Squibb (BMS) this week appointed Chris Shibutani as executive vice president, chief strategy officer, effective immediately. Shibutani’s role is a new position on the BMS leadership team. The announcement was made on a LinkedIn post.Shibutani will lead the development and advancement of the company’s long-term strategic plan, collaborating across the enterprise to drive innovation and growth. He brings more than 25 years of experience in the financial services industry covering global pharmaceutical, biotechnology and medical device industries.Prior to BMS, Shibutani served as managing director in the global investment research division at Goldman Sachs. Previous roles include senior analyst positions at Hambrecht & Quist, Cowen, UBS, and J.P. Morgan.Before his career in finance, Shibutani was a physician trained in anesthesiology and critical care medicine at Massachusetts General Hospital and practiced at Memorial Sloan Kettering Cancer Center

PharmaData
Jun 13th, 2025
Bristol Myers Squibb Highlights Targeted Protein Degradation Data, Including CELMoD Agents, at EHA 2025

Bristol Myers Squibb highlights targeted protein degradation advances, including CELMoD agents and BCL6 Ligand-Directed Degrader, at EHA 2025 in Milan, Italy.

INACTIVE